J-Rod peripheral neuropathy
J-Rod peripheral neuropathy is an alleged progressive neurological disease afflicting the J-Rod extraterrestrial biological entities described by Dan Burisch, formally identified in the Q94 document (1994) as a paraprotein-related monoclonal gammopathy of undetermined significance (MGUS) with a CMT1A-like demyelinating process linked to PMP22 overexpression on chromosomes 5 and 17. According to Burisch, the disease was a primary driver of the J-Rod delegation's participation in the Tau-9 negotiations with Majestic 12.
Diagnosis
Burisch described action potentials dying at the synapse with heat being lost at the axolemmal ridges. A Cockayne syndrome-type presentation and supercoiled triplex DNA further complicated the pathology and reportedly made gene-therapy approaches impractical: "the Cockayne-like syndrome increased (by magnitude) the difficulty in handling the pathology, and turned the issue into an almost unimaginable multifocal process."
Treatment attempts
According to Burisch, all immunotherapy approaches — T-cell immunosuppression, plasma exchange, viral transfection — produced only minimal relief. Hyperbaric hydrogen therapy reportedly provided temporary symptomatic relief for the P-52 J-Rods assigned to the Gliese system, who suffered more severe active neuropathy.
Variation across J-Rod populations
The P-45 J-Rods from Reticulum also displayed the disease complex. According to Burisch, their skin and glandular changes during exacerbations caused abductees to perceive them as reptilian in appearance: "the particular ruddy configuration of their skin, that changes in the sudoriferous glandular structure of their skin, can make them appear, during exacerbations of the illness, very reptilian in appearance."